Stugeron
Brand names,
Stugeron
Analogs
Stugeron
Brand Names Mixture
Stugeron
Chemical_Formula
C26H28N2
Stugeron
RX_link
No information avaliable
Stugeron
fda sheet
Stugeron
msds (material safety sheet)
Stugeron
Synthesis Reference
No information avaliable
Stugeron
Molecular Weight
368.514 g/mol
Stugeron
Melting Point
No information avaliable
Stugeron
H2O Solubility
750 mg/L
Stugeron
State
Solid
Stugeron
LogP
5.63
Stugeron
Dosage Forms
No information avaliable
Stugeron
Indication
For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
Stugeron
Pharmacology
Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.
Stugeron
Absorption
No information avaliable
Stugeron
side effects and Toxicity
No information avaliable
Stugeron
Patient Information
No information avaliable
Stugeron
Organisms Affected
Humans and other mammals